Veracyte reported $-0.39 in EPS Earnings Per Share for its fiscal quarter ending in December of 2023.

Fiscal Calendar Actual Consensus Previous Date
FY2024Q1 Mar/2024 -0.16 -0.11 Apr/30 2024
FY2023Q4 Dec/2023 -0.39 -0.09 -0.05 Feb/22 2024
FY2023Q3 Sep/2023 -0.41 -0.15 -0.12 Nov/07 2023
FY2023Q2 Jun/2023 -0.12 -0.15 -0.13 Aug/08 2023
FY2023Q1 Mar/2023 -0.11 -0.15 -0.2 May/04 2023
FY2022Q4 Dec/2022 -0.05 -0.15 -0.15 Feb/22 2023
FY2022Q3 Sep/2022 -0.12 -0.24 -0.2 Nov/02 2022
FY2022Q2 Jun/2022 -0.13 -0.22 -0.13 Aug/02 2022
FY2022Q1 Mar/2022 -0.2 -0.24 -0.11 May/03 2022
FY2021Q4 Dec/2021 -0.15 -0.18 -0.14 Feb/28 2022
FY2021Q3 Sep/2021 -0.2 -0.17 -0.08 Nov/09 2021
FY2021Q2 Jun/2021 -0.13 -0.25 -0.22 Jul/29 2021

Eps Change Date
Agilent USD 1.29 0.09 Dec/2023
Arrowhead Research USD -1.24 0.22 Dec/2023
Bruker USD 0.8 0.06 Dec/2023
Exact Sciences USD -0.27 0.18 Dec/2023
Illumina USD 0.14 0.19 Dec/2023
Laboratory Of America USD 3.68 0.38 Mar/2024
Ligand Pharmaceuticals USD 1.38 0.36 Dec/2023
Myriad Genetics USD 0.04 0.07 Dec/2023
Roche Holding CHF 8.47 1.63 Dec/2023
Siemens EUR 2.99 0.85 Dec/2023
Sonic Healthcare AUD 0.43 0.22 Dec/2023
Thermo Fisher Scientific USD 5.11 0.56 Mar/2024
Veracyte USD -0.39 0.02 Dec/2023
Waters USD 3.62 0.78 Dec/2023